Cancers (Jan 2023)

Inflammation and Prostate Cancer: Pathological Analysis from Pros-IT CNR 2

  • Francesco Sessa,
  • Rossella Nicoletti,
  • Cosimo De Nunzio,
  • Angelo Porreca,
  • Stefano Maria Magrini,
  • Vincenzo Mirone,
  • Andrea Tubaro,
  • Sergio Serni,
  • Paolo Gontero,
  • Marianna Noale,
  • Stefania Maggi,
  • Mauro Gacci,
  • on behalf of the Pros-IT2 Study Group

DOI
https://doi.org/10.3390/cancers15030630
Journal volume & issue
Vol. 15, no. 3
p. 630

Abstract

Read online

Background: Extensive research effort has been devoted to investigating the link between inflammation and PCa. However, this relationship remains unclear and controversial. The aim of our multi-center study was to investigate this association by histologically evaluating the distribution of PI and PCA in prostate biopsy cores from patients of eight referral centers in Italy. Results: We evaluated 2220 cores from 197 patients; all the frustules were re-evaluated by dedicated pathologists retrospectively. Pathologists assigned IRANI scores and determined the positions of PIs; pathologists also re-evaluated the presence of PCa and relative ISUP grade. PCa was recorded in 749/2220 (33.7%). We divided this sample into a PCa PI group (634/749 cores [84.7%]) and a non-PCa + PI group (1157/1471 cores [78.7%]). We observed a statistically significant difference in the presence of inflammation among cores with cancer (p p < 0.01). Conclusions: In our experience, there is evidence of an association between PI and PCa at a tissue level. Further studies are needed to confirm our findings and to identify patients who might benefit from target therapies to prevent PCa occurrence and/or progression.

Keywords